肾脏转录组测序提升Alport谱系分子诊断并揭示剪接复杂性
本研究对93例有肾小球基底膜超微结构异常患者的肾活检组织进行全转录组测序,结合组织病理和临床数据。转录组测序在56%患者中检出致病或可能致病变异,包括22%剪接变异,并发现与eGFR下降相关的炎症和促纤维化通路激活及肾转运体基因抑制。
要点
- 肾脏转录组测序可提高Alport谱系分子诊断率,尤其有助于解读剪接变异。
- 转录组测序在56%患者中检出致病或可能致病变异,其中22%为剪接变异。
- 基因表达谱揭示与eGFR下降相关的炎症、促纤维化通路激活及肾转运体基因抑制。
核心结论
- 肾脏转录组测序改善Alport谱系分子诊断,能解读剪接变异并捕捉与进展相关的分子特征。
研究设计与样本
- 对93例有肾小球基底膜超微结构异常患者的肾活检组织进行全转录组测序,整合组织病理、电镜和临床数据。
主要发现
- 转录组测序检出64个致病或可能致病变异,包括14个剪接变异(22%)。
- 52例(56%)患者检出致病或可能致病变异,涉及COL4A3、COL4A4、COL4A5和CLCN5。
- 定量剪接分析揭示COL4A4外显子27跳跃异质性,提示存在调控性外显子使用。
- 基因表达谱显示与eGFR相关的进行性重构,炎症和促纤维化通路激活,肾转运体基因受抑制。
- miRNA富集分析提示miR-335-5p、miR-325-3p和miR-874-3p可能为潜在调控因子。
临床怎么用
- 对疑似Alport谱系且DNA测序未明确诊断者,可考虑肾脏转录组测序辅助分子诊断和剪接变异解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Hereditary glomerular basement membrane (GBM) disorders caused by pathogenic variants in COL4A 3/A4/A5 are increasingly recognized as Alport spectrum. Disease severity varies widely and is influenced by variant type, allelic dosage, sex, and genetic modifiers. DNA-based testing incompletely captures this heterogeneity, particularly splice-altering and regulatory variants, limiting precise molecular diagnosis and prognostic stratification. METHODS: We performed whole-transcriptome sequencing on 93 kidney biopsies from 93 patients (90 families) with ultrastructural GBM abnormalities. RNA-derived variant detection, splicing analysis, and gene expression profiling were integrated with histopathology, electron microscopy, and clinical data. Aberrant splicing events were quantified, and differential gene expression and microRNA (miRNA) motif enrichment analyses assessed molecular changes associated with kidney function decline. RESULTS: Transcriptome sequencing identified 64 pathogenic or likely pathogenic variants, including 14 splice-altering variants (22%), often involving noncanonical events, whose functional consequences are not readily resolved by routine DNA sequencing alone. Pathogenic or likely pathogenic variants were detected in 52 of 93 patients (56%), including novel missense and splice-altering variants in COL4A3, COL4A4, COL4A5, and CLCN5. Quantitative splicing revealed heterogeneous exon 27 skipping in COL4A4, indicating regulated exon usage. Gene expression profiling showed progressive estimated glomerular filtration rate (eGFR)-associated remodeling with activation of inflammatory and profibrotic pathways and suppression of renal transporter genes. miRNA enrichment implicated miR-335-5p, miR-325-3p, and miR-874-3p as potential regulators. CONCLUSION: Kidney transcriptome sequencing improves molecular diagnosis across the Alport spectrum, enables interpretation of splice-altering variants, and captures signatures linked to progression. Integrating RNA-based analysis may refine classification, enhance prognostic assessment, and support precision medicine in hereditary nephropathies.
引用
- Pleško J, Kert Š, Petrin S, et al. Kidney Transcriptome Sequencing Improves Molecular Diagnosis and Reveals Splicing Complexity Across the Alport Spectrum. Kidney Int Rep. 2026. PMID: 42614610. doi:10.1016/j.ekir.2026.106710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。